These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33469091)

  • 1. Usefulness of
    Lee DY; Lee SH; Kim BJ; Kim W; Yoon PW; Lee SJ; Oh SJ; Koh JM; Ryu JS
    Sci Rep; 2021 Jan; 11(1):1819. PubMed ID: 33469091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of
    Kato A; Nakamoto Y; Ishimori T; Hayakawa N; Ueda M; Temma T; Sano K; Shimizu Y; Saga T; Togashi K
    Ann Nucl Med; 2021 Mar; 35(3):397-405. PubMed ID: 33582980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of
    Yu HN; Liu L; Chen QS; He Q; Li YS; Wang Y; Gao S
    Orthop Surg; 2021 May; 13(3):791-798. PubMed ID: 33709632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of 18F-AlF-NOTA-Octreotide PET/CT in the Localization of Tumor-Induced Osteomalacia.
    Long T; Hou J; Yang N; Zhou M; Li Y; Li J; Tang Y; Chen D; Hu S
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4202-e4209. PubMed ID: 33864458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ga-68 DOTATOC PET/CT-Guided Biopsy and Cryoablation with Autoradiography of Biopsy Specimen for Treatment of Tumor-Induced Osteomalacia.
    Maybody M; Grewal RK; Healey JH; Antonescu CR; Fanchon L; Hwang S; Carrasquillo JA; Kirov A; Farooki A
    Cardiovasc Intervent Radiol; 2016 Sep; 39(9):1352-7. PubMed ID: 27150801
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Li J
    Front Endocrinol (Lausanne); 2024; 15():1400751. PubMed ID: 38887276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of
    Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic efficiency of
    He Q; Zhang B; Zhang L; Chen Z; Shi X; Yi C; Wang X; Zhang X
    Eur Radiol; 2021 Apr; 31(4):2414-2421. PubMed ID: 33021702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of
    Sawicki LM; Deuschl C; Beiderwellen K; Ruhlmann V; Poeppel TD; Heusch P; Lahner H; Führer D; Bockisch A; Herrmann K; Forsting M; Antoch G; Umutlu L
    Eur Radiol; 2017 Oct; 27(10):4091-4099. PubMed ID: 28439648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic osteomalacia: role of Ga-68 DOTANOC PET/CT scan in identifying the culprit lesion and its management.
    Singh D; Chopra A; Ravina M; Kongara S; Bhatia E; Kumar N; Gupta S; Yadav S; Dabadghao P; Yadav R; Dube V; Kumar U; Dixit M; Gambhir S
    Br J Radiol; 2017 Apr; 90(1072):20160811. PubMed ID: 28181822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of Ga-68 DOTA-SSTR and F-18 FDG PET/CT in the detection of culprit tumours causing osteomalacia: a systematic review and meta-analysis.
    Agrawal K; Padhy BM; Meher BR; Mohanty RR
    Nucl Med Commun; 2021 Jun; 42(6):646-655. PubMed ID: 33625187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-Positive
    Parghane RV; Basu S
    J Nucl Med Technol; 2023 Mar; 51(1):73-74. PubMed ID: 35197273
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity Comparison of
    Nicolas GP; Schreiter N; Kaul F; Uiters J; Bouterfa H; Kaufmann J; Erlanger TE; Cathomas R; Christ E; Fani M; Wild D
    J Nucl Med; 2018 Jun; 59(6):915-921. PubMed ID: 29191855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance and impact on patient management of
    Paquet M; Gauthé M; Zhang Yin J; Nataf V; Bélissant O; Orcel P; Roux C; Talbot JN; Montravers F
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids.
    Jindal T; Kumar A; Venkitaraman B; Dutta R; Kumar R
    Korean J Intern Med; 2010 Dec; 25(4):386-91. PubMed ID: 21179276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective localization in tumor-induced osteomalacia using
    Kawai S; Ariyasu H; Furukawa Y; Yamamoto R; Uraki S; Takeshima K; Warigaya K; Nakamoto Y; Akamizu T
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28469928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga DOTA-TATE PET/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT/CT.
    Breer S; Brunkhorst T; Beil FT; Peldschus K; Heiland M; Klutmann S; Barvencik F; Zustin J; Gratz KF; Amling M
    Bone; 2014 Jul; 64():222-7. PubMed ID: 24769333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Whole-Body PET Volumetric Parameters Extracted from
    Thuillier P; Liberini V; Grimaldi S; Rampado O; Gallio E; Santi B; Arvat E; Piovesan A; Filippi R; Abgral R; Molinari F; Deandreis D
    J Nucl Med; 2022 Jul; 63(7):1014-1020. PubMed ID: 34740949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1.
    Albers MB; Librizzi D; Lopez CL; Manoharan J; Apitzsch JC; Slater EP; Bollmann C; Kann PH; Bartsch DK
    World J Surg; 2017 Jun; 41(6):1521-1527. PubMed ID: 28138732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.